Hollsteen
← Teradyne

Total liabilities & equity

Balance – as of period end · $M

QuartersFiscal years

$MTotal liabilities & equity · Q1 2016: $2.5B · 10-Q 0001193125-16-589497 filed May 13, 2016Total liabilities & equity · Q2 2016: $2.4B · 10-Q 0001193125-16-680412 filed Aug 12, 2016Total liabilities & equity · Q3 2016: $2.4B · 10-Q 0001193125-16-765452 filed Nov 10, 2016Total liabilities & equity · Q4 2016: $2.8B · 10-K 0001193125-17-064638 filed Mar 1, 2017Total liabilities & equity · Q1 2017: $2.8B · 10-Q 0001193125-17-168243 filed May 12, 2017Total liabilities & equity · Q2 2017: $3.0B · 10-Q 0001193125-17-255654 filed Aug 11, 2017Total liabilities & equity · Q3 2017: $3.1B · 10-Q 0001193125-17-338478 filed Nov 9, 2017Total liabilities & equity · Q4 2017: $3.1B · 10-K 0001193125-18-066579 filed Mar 1, 2018Total liabilities & equity · Q1 2018: $3.0B · 10-Q 0001193125-18-160479 filed May 11, 2018Total liabilities & equity · Q2 2018: $2.9B · 10-Q 0001193125-18-245633 filed Aug 10, 2018Total liabilities & equity · Q3 2018: $2.9B · 10-Q 0001193125-18-323422 filed Nov 9, 2018Total liabilities & equity · Q4 2018: $2.7B · 10-K 0001193125-19-059974 filed Mar 1, 2019Total liabilities & equity · Q1 2019: $2.6B · 10-Q 0001193125-19-143836 filed May 10, 2019Total liabilities & equity · Q2 2019: $2.7B · 10-Q 0001193125-19-217772 filed Aug 9, 2019Total liabilities & equity · Q3 2019: $2.7B · 10-Q 0001193125-19-288119 filed Nov 8, 2019Total liabilities & equity · Q4 2019: $2.8B · 10-K 0001193125-20-058676 filed Mar 2, 2020Total liabilities & equity · Q1 2020: $2.8B · 10-Q 0001193125-20-132242 filed May 4, 2020Total liabilities & equity · Q2 2020: $3.2B · 10-Q 0001193125-20-207892 filed Aug 3, 2020Total liabilities & equity · Q3 2020: $3.4B · 10-Q 0001193125-20-283796 filed Nov 2, 2020Total liabilities & equity · Q4 2020: $3.7B · 10-K 0001193125-21-050735 filed Feb 22, 2021Total liabilities & equity · Q1 2021: $3.7B · 10-Q 0001193125-21-154707 filed May 7, 2021Total liabilities & equity · Q2 2021: $4.0B · 10-Q 0001193125-21-238886 filed Aug 6, 2021Total liabilities & equity · Q3 2021: $3.8B · 10-Q 0001193125-21-321554 filed Nov 5, 2021Total liabilities & equity · Q4 2021: $3.8B · 10-K 0001193125-22-049828 filed Feb 23, 2022Total liabilities & equity · Q1 2022: $3.6B · 10-Q 0001193125-22-143504 filed May 6, 2022Total liabilities & equity · Q2 2022: $3.5B · 10-Q 0001193125-22-213485 filed Aug 5, 2022Total liabilities & equity · Q3 2022: $3.3B · 10-Q 0001193125-22-277821 filed Nov 4, 2022Total liabilities & equity · Q4 2022: $3.5B · 10-K 0001193125-23-044711 filed Feb 22, 2023Total liabilities & equity · Q1 2023: $3.4B · 10-Q 0001193125-23-136994 filed May 5, 2023Total liabilities & equity · Q2 2023: $3.4B · 10-Q 0001193125-23-203780 filed Aug 4, 2023Total liabilities & equity · Q3 2023: $3.4B · 10-Q 0000950170-23-058679 filed Nov 3, 2023Total liabilities & equity · Q4 2023: $3.5B · 10-K 0000950170-24-018701 filed Feb 22, 2024Total liabilities & equity · Q1 2024: $3.4B · 10-Q 0000950170-24-052761 filed May 3, 2024Total liabilities & equity · Q2 2024: $3.6B · 10-Q 0000950170-24-089858 filed Aug 2, 2024Total liabilities & equity · Q3 2024: $3.8B · 10-Q 0000950170-24-119923 filed Nov 1, 2024Total liabilities & equity · Q4 2024: $3.7B · 10-K 0000950170-25-023784 filed Feb 20, 2025Total liabilities & equity · Q1 2025: $3.7B · 10-Q 0000950170-25-062503 filed May 2, 2025Total liabilities & equity · Q2 2025: $3.8B · 10-Q 0000950170-25-101248 filed Aug 1, 2025Total liabilities & equity · Q3 2025: $4.0B · 10-Q 0001193125-25-258477 filed Oct 30, 2025Total liabilities & equity · Q4 2025: $4.2B · 10-K 0001193125-26-059002 filed Feb 19, 2026Total liabilities & equity · Q1 2026: $4.4B · 10-Q 0001193125-26-201058 filed May 1, 2026Total liabilities & equity · Q2 2026: $4.9B · 10-Q 0001193125-26-327715 filed Jul 31, 20263,3834,9262,549Q1 2016Q2 2026Q1 2023
Q1 2023
3,383$M
All values (42)
PeriodValue ($M)Status
Q2 20264,926reported
Q1 20264,434reported
Q4 20254,184reported
Q3 20253,964reported
Q2 20253,762reported
Q1 20253,706reported
Q4 20243,709reported
Q3 20243,770reported
Q2 20243,632reported
Q1 20243,411reported
Q4 20233,487reported
Q3 20233,371reported
Q2 20233,395reported
Q1 20233,383reported
Q4 20223,501reported
Q3 20223,320reported
Q2 20223,488reported
Q1 20223,609reported
Q4 20213,809reported
Q3 20213,762reported
Q2 20214,001reported
Q1 20213,720reported
Q4 20203,652reported
Q3 20203,437reported
Q2 20203,249reported
Q1 20202,820reported
Q4 20192,787reported
Q3 20192,699reported
Q2 20192,672reported
Q1 20192,617reported
Q4 20182,707reported
Q3 20182,882reported
Q2 20182,932reported
Q1 20182,995reported
Q4 20173,110reported
Q3 20173,089reported
Q2 20173,030reported
Q1 20172,842reported
Q4 20162,762reported
Q3 20162,366reported
Q2 20162,408reported
Q1 20162,549reported

CSV with all sources · Technical ID: liabilities_and_equity

More metrics for Teradyne
Sources & calculation
Value
$3.4B
Period
Q1 2023, ended Apr 2, 2023 · as of Apr 2, 2023 (balance as of date, not a sum)
Source
10-Q, filed May 5, 2023 · 0001193125-23-136994
Location
us-gaap:LiabilitiesAndStockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.4BMay 5, 202310-Q 0001193125-23-136994reported · confidence 1. · current